Pulse Biosciences Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
PLSE$58.17+9.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statements and Supplementary Data
Item** 8. Financial Statements and Supplementary Data
PULSE BIOSCIENCES, INC.
Index to Consolidated Financial Statements
| Page | |
|---|---|
| Number | |
| CONSOLIDATED FINANCIAL STATEMENTS | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34) | 45 |
| Consolidated Balance Sheets | 46 |
| Consolidated Statements of Operations and Comprehensive Loss | 47 |
| Consolidated Statements of Stockholders’ (Deficit) Equity | 48 |
| Consolidated Statements of Cash Flows | 49 |
| Notes to Consolidated Financial Statements | 50 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.